c-fos expression in the amygdala:In vivo antisense modulation and role in anxiety (original) (raw)

References

• Akhtar, S., and Juliano, R. L. (1992). Cellular uptake and intracellular fate of antisense oligonucleotides.Trends Cell Biol. 2139–144.
  PubMed Google Scholar
• Arnold, F. J., De Lucas Bueno, M., Shiers, H., Hancock, D. C., Evan, G. I., and Herbert, J. (1992). Expression of c-fos in regions of the basal limbic forebrain following intracerebroventricular corticotropin-releasing factor in unstressed or stressed male rats.Neuroscience 51377–390.
  PubMed Google Scholar
• Chiasson, B. J., Hooper, M. L., Murphy, P. R., and Robertson, H. A. (1992). Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain.Eur. J. Pharmacol. 227451–453.
  PubMed Google Scholar
• Davis, M. (1992). The role of the amygdala in fear and anxiety.Annu. Rev. Neurosci. 15353–375.
  PubMed Google Scholar
• Drevets, W. C., Videen, T. O., Price, J. L., Preskorn, S. H., Carmichael, S. T., and Raichle, M. E. (1992). A functional anatomical study of unipolar depression.J. Neurosci. 123628–3641.
  PubMed Google Scholar
• Gray, T. S. (1994). Autonomic neuropeptide connections of the amygdala. In_Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide_ (E. B. DeSouza, and C. B. Nemeroff, Eds.), Springer Verlag, New York, pp. 92–106.
  Google Scholar
• Heilig, M., Pich, E. M., Koob, G. F., Yee, F., and Wahlestedt, C. (1992). In vivo downregulation of neuropeptide Y (NPY) Y1 receptors by i.c.v. antisense oligodeoxynucleotide administration is associated with signs of anxiety in rats.Soc. Neurosci. Abstr. 642.18.
• Heilig, M., Engel, J. A., and Söderpalm, B. (1993). C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine.Eur. J. Pharmacol. 263339–340.
  Google Scholar
• Heilig, M., Koob, G. F., Ekman, R., and Britton, K. T. (1994). Corticotropin-releasing factor and neuropeptide Y in mechanisms of anxiety.Trends Neurosci. 17(280–85.
  PubMed Google Scholar
• Heinrichs, S. C., Pich, E. M., Miczek, K. A., Britton, K. T., and Koob, G. F. (1992). Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.Brain Res. 581190–197.
  PubMed Google Scholar
• Johnson, R. S., Spiegelman, B. M., and Papaioannou, V. (1992). Pleiotropic effects of a null mutation in the c-fos proto-oncogene.Cell 71577–586.
  PubMed Google Scholar
• Koob, G. F., Heinrichs, S. C., Pich, E. M., Menzaghi, F., Baldwin, H., Miczek, K., and Britton, K. T. (1993). The role of corticotropin-releasing factor in behavioural responses to stress.Ciba Found. Symp. 172277–289.
  PubMed Google Scholar
• LeDoux, J. E. (1992). Brain mechanisms of emotion and emotional learning.Curr. Opin. Neurobiol. 2191–197.
  PubMed Google Scholar
• Moratalla, R., Vickers, E. A., Robertson, H. A., Cochran, B. H., and Graybiel, A. M. (1993). Coordinate expression of c-fos and jun B is induced in the rat striatum by cocaine.J. Neurosci. 13423–433.
  PubMed Google Scholar
• Morgan, J. I., and Curran, T. (1991). Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun.Annu. Rev. Neurosci. 14421–451.
  PubMed Google Scholar
• Rassnick, S., Heinrichs, S. C., Britton, K. T., and Koob, G. F. (1993). Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.Brain Res. 60525–32.
  PubMed Google Scholar
• Shephard, R. A. (1986). Neurotransmitters, anxiety and benzodiazepines: A behavioral review.Neurosci. Biobehav. Rev. 10449–461.
  PubMed Google Scholar
• Vogel, J. R., Beer, B., and Clody, D. E. (1971). A simple and reliable conflict procedure for testing anti-anxiety agents.Psychopharmacologia 211–7.
  PubMed Google Scholar
• Wahlestedt, C., Golanov, E., Yamamoto, S., Yee, F., Ericson, H., Yoo, H., Inturrisi, C. E., and Reis, D. J. (1993a). Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions.Nature 363260–263.
  PubMed Google Scholar
• Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F., and Heilig, M. (1993b). Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.Science 259528–531.
  PubMed Google Scholar
• Wang, Z. Q., Ovitt, C., Grigoriadis, A. E., Mohle-Steinlein, U., Ruther, U., and Wagner, E. F. (1992). Bone and haematopoietic defects in mice lacking c-fos.Nature 360741–745.
  PubMed Google Scholar
• Whitesell, L., Geselowitz, D., Chavany, C., Fahmy, B., Walbridge, S., Alger, J. R., and Neckers, L. M. (1993). Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system.Proc. Natl. Acad. Sci. USA 904665–4669.
  PubMed Google Scholar
• Wisden, W., Errington, M. L., Williams, S., Dunnett, S. B., Waters, C., Gitchcock, D., Evan, G., Bliss, T. V., and Hunt, S. P. (1990). Differential expression of immediate early genes in the hippocampus and spinal cord.Neuron 4603–614.
  PubMed Google Scholar
• Woolf., T. M., Melton, D. A., and Jennings, C. G. (1992). Specificity of antisense oligonucleotides in vivo.Proc. Natl. Acad. Sci. USA 897305–7309.
  PubMed Google Scholar

Download references